Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors.

Aminoguanidine decreases the formation of advanced glycosylation end products that occurs during chronic hyperglycemia. Presumably this occurs because early glycosylation products preferentially bind to aminoguanidine rather than to lysine groups of adjacent proteins. Because oxidative modification...

Full description

Saved in:
Bibliographic Details
Main Authors: Picard, S, Parthasarathy, S, Fruebis, J, Witztum, J L
Format: Artigo
Language:Inglês
Published: 1992
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC49607/
https://ncbi.nlm.nih.gov/pubmed/1495978
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items